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Abstract
Background: Non-motor symptoms, quality of life, service needs, and barriers to care of individuals with movement disorders are not well explored. This study
assessed these domains within a sample of individuals with essential tremor (ET) and Parkinson’s disease (PD).
Methods: A survey exploring symptoms, needs, and barriers to care was disseminated to a convenience sample (N596) of individuals with a primary diagnosis of
ET (N519) or PD (N577).
Results: Similarities in overall quality of life and impact on daily functioning were found across individuals with ET and PD. Noteworthy differences included
endorsement of different types of service needs and utilization patterns and fewer non-motor symptoms reported among those with ET (M56.1, SD52.4) than those
with PD (M510.4, SD53.4). Non-motor symptoms significantly impacted movement disorder-related quality of life for both diagnostic groups, but this relationship
was stronger for individuals with ET, t(12)53.69, p50.003, b50.73 than with PD, t(56)54.00, p,0.001, b50.47. Individuals with ET also reported higher rates of
stigma (31.6% vs. 7.8%) and greater impact of non-motor symptoms on emotional well-being, R250.37, F(1, 13)57.17, p50.020.
Discussion: This is the first study to describe and compare the needs, barriers to care, and impact on quality of life of two distinct movement disorder groups. Our
results support the recent efforts of the field to identify interventions to address the non-motor symptoms of movement disorders and indicate need for greater
appreciation of the specific differences in symptoms and quality of life experienced across movement disorder diagnoses.
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Introduction
In the twenty-first century, Parkinson’s disease (PD) is now best
conceptualized as a neurodegenerative disease with neurocognitive
symptoms that gradually develop and progressively compromise
individuals’ quality of life (QOL) and independence. While essential
tremor (ET) was classically considered a monosymptomatic tremor
disorder, non-motor clinical symptoms, including cognitive and mood
issues, are now increasingly recognized as important features of the
disease.1–3 A shift in the research community’s focus to non-motor
symptoms (NMS) of movement disorders (MDs) has begun. NMS,
including neuropsychiatric symptoms, sleep disorders, autonomic,
gastrointestinal, sensory, and cognitive impairments,4 have been
identified as having a significant impact on QOL in individuals with
PD5–7 and risk of institutionalization at advanced stages of PD.8
Furthermore, in PD, over 90% of patients endorse NMS across all stages
of the disorder,9 and often require additional health care services to
manage their disorders and improve their QOL. Research focused on
NMS among individuals with ET is just emerging, but recent studies
suggest some important differences between those with PD and those
with ET in the frequency and type of NMS reported.10,11
Despite the prevalence of these disorders and growing awareness of
the impact of NMS on QOL, little is known about patient-reported
needs and barriers to care of individuals with MDs. While patient
needs related to the motor and non-motor symptoms of MDs are
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increasingly recognized by MD specialists, patient perspectives about
which symptoms are most bothersome and whether other needs exist
remain unknown. Barriers to care may also limit access to treatments.
Barriers include financial (i.e., cost of service, lack of insurance), social
(i.e., stigma, family stressors), and instrumental (i.e., transportation,
lack of availability) factors that inhibit access to care.
This study aimed to elicit patient-reported needs and barriers to
care and evaluate patient-reported QOL, frequency of NMS, and the
impact of NMS on QOL. Caregivers were also studied and their
perspectives are under review. Consistent with prior research, we
anticipated that a greater number of NMS would impact both health-
related and overall QOL, that patients would equally endorse service
needs for care of motor and NMS, but that patients would endorse
currently receiving services for motor symptoms more frequently than
for NMS. We prioritized obtaining patient-reported needs and barriers
to care to improve our understanding of patient perspectives.
Methods
Participants
Participants were adults ages 21 years and over who self-identified as
having a MD diagnosis (N596), with individuals reporting a primary
diagnosis of either ET (N519) or PD (N577) (Table 1). Participants
were recruited by advertisements shared through the clinic’s listserv,
website, partner community organizations, and support groups. The
advertisements explained that an online questionnaire had been
developed, which would ask individuals with a MD to answer
questions about their current use of health care services and barriers
to care that prevent access to care for their MD. Potential participants
were informed that this information was being gathered to improve
understanding of their needs and any barriers to accessing needed
care. Interested individuals were provided a link to the online survey or
provided paper questionnaires with a pre-paid return envelope if
requested. Access to a larger sample, and importantly individuals who
may not be accessing care for their MD, was prioritized over limiting
the survey to individuals who receive care and have medical records at
our center; however, this decision resulted in only patient reports of
medical diagnosis, stage, etc.
The study was completed with adequate understanding and consent
of the subjects involved and with the ethical approval of the
Institutional Review Board. Participants provided electronic waivers
or written informed consent for online and paper surveys respectively.
Procedure
This study was conducted at an interdisciplinary MD specialty clinic
in southeastern Virginia during the period of May–December 2012
and involved dissemination of a web-based survey. Participants were
provided with a link or paper form if requested. Survey data were
collected and managed in a secure, web-based database (Research
Electronic Data Capture [REDCap]).12 The survey was disseminated
primarily to the local communities surrounding the clinic location to
inform clinical and research program development at the center;
however, use of a single site somewhat limits generalizations that can
be made from the survey.
Measures
Content of the survey questions was compiled from empirical
literature and national resources on the needs of individuals with MD
and are described below. To minimize burden while providing
opportunity for comments, checklists and free-response options were
provided. All responses were provided by the participants themselves,
including self-report of cognitive diagnoses and stage of disorder.
Non-motor symptoms and quality of life. Standardized assessment
tools for evaluating NMS, overall and health-related QOL, and the
impact of health problems on work and daily activity productivity were
included in the survey. Importantly, the NMS and health-related QOL
scales were originally developed and validated for use in a PD
population and while an ET-specific QOL questionnaire exists,3 we
selected the Parkinson’s Disease Queotionnaire-39 (PDQ-39) to
facilitate comparison to PD and evaluate cognitive and stigma-related
symptoms. As a result, we used these tools as a first step to explore
comparisons across diagnostic groups and evaluate how these factors
differ among various MDs. The wording of these questionnaires was
altered only to reflect the inclusion of individuals with MDs rather than
exclusively PD.
NMS were evaluated using the Parkinson’s Disease Non-Motor
Symptom Questionnaire (PD-NMS), a 30-item questionnaire that asks
participants to indicate whether or not they have experienced various
NMS in the past month.13 A total raw score is calculated based on the
number of NMS experienced in the past month, with higher scores
indicating greater number of symptoms.
The PDQ-39 was used to evaluate the impact of a MD on QOL
across eight domains, including Bodily Discomfort, Mobility, Activities
of Daily Living, Emotional Well Being, Communication, Cognitive
Impairment, Stigma, and Social Support.14 Raw total scores and raw
domain scores were transformed to a 0–100 scale to allow for
comparison across domains and with other studies using the PDQ-39,
with higher scores indicating greater negative impact of the MD on
QOL.
General QOL was also assessed using the Linear Analog Scale
Assessment (LASA), which has been demonstrated to validly assess
general well-being as well as specific domains of QOL (i.e., emotional,
physical, intellectual and spiritual) with single items on a 0 (As bad as it
can be) to 10 (As good as it can be) scale.15
Work productivity. The impact of disease on work productivity and
leisure activities was evaluated with the Work Productivity and Activity
Impairment-General Health questionnaire (WPAI-GH).16 Participants
were asked to provide objective information on their number of hours
worked, number of hours missed from work due to health problems,
and were also asked to rate how much health problems affected work
productivity as well as other regular daily activities on a scale ranging
from 0 (Health problems had no effect on my work/my daily activities) to 10
(Health problems completely prevented me from working/doing my daily activities).
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Table 1. Sample Characteristics
Sample Characteristic PD (N577) ET (N519)







Native American 2.6 0.0
Hispanic/Latino 1.3 0.0
Pacific islander 0.0 5.3
Educational level (%)
GED 1.3 0.0
High school graduate 7.8 10.5
Vocational training or associate’s degree 20.8 21.1
Bachelor’s degree 36.4 47.4
Master’s degree 22.1 15.8
Professional/doctoral degree 11.7 5.3
Employment status (%)
Retired 58.4 63.2
Full time 15.6 15.8
Part time 10.4 5.3
On disability 11.7 0.0
Unemployed, but not retired or on disability 3.9 5.3
Household income (%)





Greater than $105,001 13.0 10.5
Prefer not to answer 15.6 21.1
Insurance holder (%)
Self 72.7 63.2
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Needs and barriers. In the needs assessment section, participants were
asked to review a list of topics and select their current needs, services
they are receiving, most important services for managing a MD, and
most needed services. In the barriers to care section, participants were
asked to select barriers that have affected their ability to access services.
The list of needs and barriers presented in Table 2 reflects the wording
of the checklist included in the survey.
The aims and hypotheses of this study were evaluated using
descriptive statistics and regression analyses. Descriptive statistics were
used to summarize the most frequently endorsed patient needs and
barriers to accessing care. Exploratory regression analyses were used to
model relationships between NMS and QOL and examine the
individual contribution of NMS to specific aspects of QOL.
Results
Needs and barriers to care assessment
Areas of need are presented in Table 2. As predicted, areas of need
related to NMS (i.e., wellness strategies, thinking changes) were rated
Table 1. Continued
Sample Characteristic PD (N577) ET (N519)
Family member 18.2 31.6
Uninsured 3.9 5.3
Other 5.2 0.0
Type of medical insurance (%)
Medicare 61.0 52.6
Anthem Blue Cross Blue Shield 36.4 21.1





Cognitive impairment 0.0 0.0
Mild cognitive impairment 16.9 5.3
Dementia 1.3 0.0
Mean number of years since diagnosis1 6.00 13.00
(N598) (SD) (5.68) (12.75)
(Range) (0–28) (0–38)
Stage of disorder1 (%)
Stable 45.5 26.3
Progressive 42.9 57.9
Rapidly progressive 1.3 0.0
Other 2.6 0.0
Do not know 6.5 15.8
ET, Essential Tremor; GED, General Educational Development; PD, Parkinson’s Disease; SD, Standard Deviation.
1All responses were self-reported.
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Table 2. Needs and Barriers to Care Assessment for Individuals with PD or ET
Patient Need PD Patients (N577) ET Patients (N519)
Endorsed Need (%) Endorsed Need (%)
Symptom management 67.5 52.6
Tremor/gait/balance problems 50.6 31.6
Speech/communication problems 40.3 5.3
Common medication side effects 28.6 21.1
Issues with swallowing 22.1 0
Incontinence 23.4 0
Sexual problems 15.6 0
Vision changes/issues 18.2 0
Communicating with treating doctors 13.0 10.5
Planning for the future 59.7 21.1
Long-term care planning 42.9 5.3
Financial concerns 36.4 5.3
Resource identification and accessing resources 27.3 15.8
Legal issues 18.2 0.0
Wellness strategies 54.5 26.3
Beginning an exercise regime or adapting one to fit
personal needs
44.2 21.1
Nutritional changes and healthy eating strategies 36.4 15.8
Spirituality 13.0 15.8
Lifestyle changes 54.5 15.8
Driving 39.0 5.3
Vacationing and travel tips 35.1 10.5
Fall prevention 32.5 5.3
Safety in the home 31.2 5.3
Thinking changes 50.6 15.8
Expressing self 40.3 10.5
Memory 37.7 10.5
Attention 26.0 5.3
Problem solving 19.5 0.0
Stress management 31.2 36.8
Relationship changes 29.9 5.3
Maintaining a social life 22.1 5.3
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Table 2. Continued
Changes in personal relationships post diagnosis 11.7 0.0
Identifying emotional support systems 13.0 5.3
Role changes 6.5 0.0
Parenting-related issues 0.0 0.0
Emotional changes 29.9 10.5
Experiencing anxiety, depression and apathy 24.7 10.5
Work-related issues 23.4 21.1
Disclosing your diagnosis: how to and if you should 10.4 15.8
Balancing family, medical and health responsibilities with
work duties
10.4 10.5
Transitioning from FT to PT work 7.8 0.0
Analyzing transferable skills and new/different job
possibilities
3.9 5.3
Advocating for accommodations 3.9 0.0
Caregiver stress 26.0 5.3
Personality/behavioral changes 20.8 0.0
Visual hallucinations 7.8 0.0
Inappropriate behaviors 3.9 0.0
Aggression 2.6 0.0
Patient education about diagnosis 19.5 5.3
Adjustment to diagnosis 15.6 10.5
Early onset diagnosis 13.0 5.3
Other 2.6 0.0
Barriers to Care PD Patients (N577) ET Patients (N519)
Endorsed Need (%) Endorsed Need (%)
Cost of service 27.3 10.5
Insurance does not cover cost of service 18.2 15.8
Service/specialist not available in local area 14.3 5.3
Balancing family, work and medical issues 13.0 26.3
Stigma associated with having a movement disorder 7.8 31.6
Limited transportation 7.8 0.0
Lack of coordinated care 13.0 5.3
Limited support from family 7.8 5.3
ET, Essential Tremor; FT, Full Time; PD, Parkinson’s Disease; PT, Part Time.
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as highly as areas of need related to motor symptoms (i.e., symptom
management of tremor/gait/balance problems); however, this was
primarily true for individuals with PD. Patients with ET endorsed
fewer needs overall, and this was especially true with regards to non-
motor needs, although stress management was highly endorsed.
Overall, participants selected symptom management as their area of
greatest need, and other highly ranked areas included planning for the
future, wellness strategies, lifestyle changes, stress management, and
thinking changes. Financial and instrumental barriers were endorsed
most often in our sample, with cost of service, non-coverage of the
service, and unavailability of a local specialist, as the most frequently
endorsed barriers (Table 2).
While individuals with PD rated neurology as the service most
highly needed, contrary to prediction, none of the services related to
care of NMS were selected as frequently (Table 3). However, exercise
groups and support groups were rated as highly needed services.
Importantly, individuals with ET endorsed greatest need for support
groups. As expected, a large percentage of participants reported
currently receiving neurology and pharmacy services, but smaller
percentages reported receiving services specifically for care of NMS
(Table 3). Notably, individuals with ET reported receiving counseling
services more frequently than individuals with PD.
Non-motor symptoms and quality of life
On the PD-NMS questionnaire, individuals with PD endorsed 10
NMS per month, while individuals with ET endorsed fewer, at
approximately six NMS per month (Table 4). Overall QOL assessed
with the LASA was positive and not notably different in PD and ET.
On the PDQ-39 mean scaled scores generally ranged from seven to 31
across the domains. The greatest negative impact on QOL was found
for Bodily Discomfort. Individuals with PD reported greater negative
impact on domains of Mobility, Communication, and Cognitive
Impairment, whereas those with ET reported more difficulty with
Stigma, Activities of Daily Living, and Emotional Well Being. The
domain with the least MD-related impact was Social Support for both
groups.
On the WPAI-GH, approximately one-quarter of patients reported
currently being employed. Of those currently working, individuals with
ET reported working nearly full time, while those with PD reported
working just over part-time hours. The reported impact of health
problems on work attendance and productivity was minimal. Within
the full sample, average ratings of the impact of health problems on
other regular daily activities were also low, indicating minimal effects
of health problems on activities of daily living in this sample.
Two exploratory linear regressions were performed to test the
hypothesis that non-motor symptom frequency would be significantly,
negatively related to PD- and ET-related QOL. For both analyses of
those with PD and ET, the models were significant and indicated that
a higher score on the PD-NMS was significantly associated with higher
scores on the PDQ-39 total scaled score, PD, R250.22, F(1,
56)516.02, p,0.001, ET, R250.53, F5(1, 12)513.64, p50.003.
The individual contribution of the PD-NMS was 1.74, t(56)54.00,
p,0.001, b50.47 for those with PD and was 3.05, t(12)53.69,
p50.003, b50.73 for those with ET, which indicated that for every
additional NMS reported, participants’ health-related QOL negatively
increased by nearly 2 and 3 additional points, for PD and ET
respectively. Thus, the contribution of NMS in estimating QOL was
somewhat stronger for those with ET than PD.
Linear regressions were also performed to evaluate the predictive
value of the PD-NMS in determining general QOL, measured with
LASA single items. The PD-NMS was not found to be significantly
related to overall well-being, physical well-being, or spiritual well-being
for both individuals with PD and ET. The PD-NMS was found to be
significantly associated with intellectual well-being in PD, R250.11,
F(1, 57)56.89, p50.011 and with emotional well-being in ET,
R250.37, F(1, 13)57.17, p50.020.
Discussion
In this study, both similarities and unique differences were found
among individuals with ET and PD. Consistent with the previous
literature,1–8 participants endorsed need for care of NMS as often as
motor symptoms. Yet, only a small percentage of our sample reported
currently receiving services for NMS. This discrepancy between NMS
needs and actual service delivery indicates that efforts to increase both
evaluation and treatment of NMS remains a priority in managing
MDs. New focus on developing research trials targeting NMS is also
critical to improve patient-centered care for individuals with MD, as
noted by the Movement Disorder Society.17 Patient education about
available NMS services and research trials are important first steps in
closing the gap between unmet needs and existing services.
Sleep, cognitive, and mood problems and symptoms were most
highly endorsed, but untreated in our sample. Given the high
prevalence of cognitive and mood symptoms in MDs,18 development
and adaptation of psychosocial and neurocognitive interventions for
the MD population is a research priority. There is a dearth of research
evaluating psychosocial interventions for individuals with MDs; yet,
substantial support in other chronic illnesses of advanced age (i.e.,
psychosocial interventions in Alzheimer’s19 and age-related macular
degeneration20) show promise for their application in MDs.
Exploration of protective factors (i.e., social support, religion/
spirituality, relationships with health care providers) that allow
individuals with MDs to thrive despite the challenges of living with
chronic illness may also reveal strategies to help foster resilience and
optimize quality of life.
Interestingly, participants rated exercise groups and, especially
among those with ET, support groups, as highly needed services,
indicating patient preference for psychosocial supports to help them
manage their disease. These findings are consistent with overall
endorsement in our sample for needing assistance with planning for
the future, wellness strategies, lifestyle changes, stress management,
and thinking changes.
However, our barriers to care assessment revealed the necessity of
going beyond patient education and research development to provide
services. Over a quarter of our participants endorsed financial and
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instrumental barriers to accessing needed services, suggesting increased
need for low or no-cost treatment options and service access beyond
major urban centers. In addition, stigma was reported as a barrier
specifically affecting individuals with ET. Advocating for greater
insurance coverage or low-cost delivery of NMS treatments and
developing telehealth services are potential ways to limit these barriers
to care. Increased community education may also target reduction of
stigma associated with ET in particular.
NMS were more highly reported among individuals with PD than
those with ET, which is consistent with one recent study examining the
differences in NMS reporting of those with PD and ET at 1 year post
diagnosis.11 While greater NMS predicted worse health-related QOL,
this was especially true for those with ET. For every additional NMS
reported, participants’ health-related QOL negatively increased by
nearly 2 and 3 additional points, for PD and ET respectively.
Interestingly, a relationship between NMS and emotional well-being
Table 3. Patient-ranked Services of Greatest Need
Service Individuals with PD Individuals with ET
Ranked Service as ‘‘Greatest’’
Need (%)
Ranked Service as ‘‘Greatest’’
Need (%)
Neurology 20.8 15.8
Exercise groups 18.2 5.3
Support group 10.4 31.6
Physical therapy 13.0 5.3
Speech/language therapy 9.1 0.0
Sleep specialist 2.6 0.0
Pharmacy 2.6 0.0
Clinical trials/research 1.3 5.3
Online/video support groups 1.3 5.3
Nutritionist 1.3 0.0
Service Individuals with PD Individuals with ET
Currently Receiving Service (%) Currently Receiving Service (%)
Neurology 72.7 31.6
Pharmacy 31.2 36.8
Physical therapy 29.9 5.3
Sleep specialist 10.4 0.0
Psychology 9.1 5.3




Occupational therapy 2.6 0.0
Genetic counseling 1.3 0.0
Social work 0.0 0.0
ET, Essential Tremor; PD, Parkinson’s Disease.
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Table 4. Non-Motor Symptoms and Psychosocial Functioning
Domain of Functioning Individuals with Parkinson’s
disease (N577)
Individuals with Essential Tremor
(N519)
Mean Score (SD) Mean Score (SD)
(Range) (Range)
Non-motor symptoms (PD-NMS) 10.4 (3.4) 6.1 (2.4)
Overall quality of life (LASA) 7.2 (1.8) 7.3 (2.2)
Spirituality 7.5 (1.9) 7.5 (2.3)
Emotional health 7.0 (2.2) 6.8 (2.2)
Intellectual functioning 6.8 (1.8) 7.8 (1.4)
Physical health 6.4 (2.0) 7.0 (2.7)
MD-related Quality of Life (PDQ-39) 22.5 (13.4) 22.0 (11.0)
(0–60.8) (6.8–40.5)
Bodily discomfort 31.4 (22.9) 28.5 (20.1)
(0–83.3) (0–66.7)
Mobility 27.5 (23.2) 20.7 (21.0)
(0–97.5) (0–77.5)
Communication 24.9 (18.6) 13.6 (19.9)
(0–75.0) (0–75.0)
Activities of daily living 23.5 (17.7) 28.3 (21.0)
(0–83.3) (4.2–62.5)
Cognitive impairment 23.5 (15.0) 19.1 (13.6)
(0–62.5) (0–56.3)
Emotional well-being 22.8 (17.7) 28.5 (15.5)
(0–79.2) (4.2–50.0)
Stigma 16.1 (17.5) 30.3 (30.2)
(0–87.5) (0–81.3)
Social support 10.4 (17.2) 7.2 (11.9)
(0–75.0) (0–41.7)
Work Productivity and Activity Impairment
(WPAI-General Health)
Are you currently employed (working for pay)? 27.3% 21.1%
During the past 7 days, how many hours did you miss
from work because of your health problems? (N520)
1.2 (2.1) 2.0 (3.5)
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was found only among those with ET. Taken together, these findings
suggest that, although more rarely experienced, the impact of NMS in
ET may be larger than it is in PD, and tailored treatments designed to
optimize emotional functioning in ET appear warranted.
This study is limited by its use of a cross-sectional, convenience sample
largely comprising Caucasian individuals from above-average household
incomes, with college education or higher, who reported relatively limited
impact of their MD on daily QOL. We also did not ask participants about
their medication usage, which could play a role in symptom presentation
and QOL; therefore, future studies should assess for these possible
treatment effects. Selection bias may have also been present, given that
participants who were willing and able to complete the survey may be less
functionally impaired than those who did not complete the survey. Bias
related to our focus on engagement with local communities may also
somewhat limit generalizability of our results. Despite efforts to recruit
participants with various MDs, this ET sample size is low and warrants
further study. Statistical tests performed on the ET group only may have
lacked statistical power or could have been skewed by a single
participant’s responses; therefore, these findings should be interpreted
with the low sample size in mind. The predominate diagnosis of PD in
our sample is likely attributed to initial focus of our clinic on PD, with
inclusion of other MDs as MD specialists joined the center. Both a
strength and limitation of this study is its reliance on self-report. Our
findings may be subject to reporting bias and psychometric limitations of
self-report instruments. However, focus on patient self-report is consistent
with our commitment to partner with community members to establish
clinical research programs responsive to patient-identified needs.
This non-motor needs and QOL assessment in individuals with
MDs represents an important step towards improving treatment and
QOL. Our focus on patient-reported areas of need helps us determine
gaps in clinical care and identify future directions for clinical research
trials. Patient-reported outcomes are just now being used to evaluate
whether new therapies for MDs are effective, such as recent PRO
evaluation of deep brain stimulation, intrajejunal levodopa infusion,
and subcutaneous apomorphine infusions.21
In the upcoming years, advances in the care of NMS are likely to be as
important, if not of even greater importance, as continued efforts to
manage the motor symptoms of these diseases. Given the impact of
NMS on QOL5–7 and risk of institutionalization at advanced stages,8
overcoming barriers to existing care options and empirically evaluating
novel treatment options are major priorities. This needs assessment
survey provides patient directives regarding improving access and
existing clinical care options and launching a patient-centered, needs-
based research agenda. Future research of a more representative sample
of MD patients and longitudinal examination of the relationship
between patients’ needs and barriers, NMS, and QOL is encouraged to
further advance our understanding of the MD community’s needs.
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